These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25065496)

  • 1. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.
    Grossniklaus HE
    Am J Ophthalmol; 2014 Nov; 158(5):875-91. PubMed ID: 25065496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma: still a challenge in developing countries.
    Mehta M; Sethi S; Pushker N; Chawla B; Ghose S
    Acta Ophthalmol; 2011 Jun; 89(4):e371. PubMed ID: 20528780
    [No Abstract]   [Full Text] [Related]  

  • 3. A personal and professional memoir of Alfred Knudson.
    Meadows AT
    Genes Chromosomes Cancer; 2003 Dec; 38(4):300-1. PubMed ID: 14566847
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior segment tumors: management 25 years ago.
    Shields JA
    Retina; 2006; 26(6 Suppl):S34-6. PubMed ID: 16832297
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of retinoblastoma.
    Fabian ID; Onadim Z; Karaa E; Duncan C; Chowdhury T; Scheimberg I; Ohnuma SI; Reddy MA; Sagoo MS
    Oncogene; 2018 Mar; 37(12):1551-1560. PubMed ID: 29321667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Available approaches to retinoblastoma therapy--literature review].
    Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models and discovery strategies for new therapies of retinoblastoma.
    Houston SK; Lampidis TJ; Murray TG
    Expert Opin Drug Discov; 2013 Apr; 8(4):383-94. PubMed ID: 23427911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontiers in the management of retinoblastoma.
    Lin P; O'Brien JM
    Am J Ophthalmol; 2009 Aug; 148(2):192-8. PubMed ID: 19477707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision].
    Temming P; Eggert A; Bornfeld N; Sauerwein W; Göricke S; Lohmann DR
    Klin Monbl Augenheilkd; 2013 Mar; 230(3):232-42. PubMed ID: 23508752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative treatment modalities in retinoblastoma.
    Chawla B; Jain A; Azad R
    Indian J Ophthalmol; 2013 Sep; 61(9):479-85. PubMed ID: 24104705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma.
    Villegas VM; Hess DJ; Wildner A; Gold AS; Murray TG
    Curr Opin Ophthalmol; 2013 Nov; 24(6):581-8. PubMed ID: 24100372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accidental cancer geneticist: hilário de gouvêa and hereditary retinoblastoma.
    Monteiro AN; Waizbort R
    Cancer Biol Ther; 2007 May; 6(5):811-3. PubMed ID: 17592249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global issues and opportunities for optimized retinoblastoma care.
    Gallie BL; Zhao J; Vandezande K; White A; Chan HS
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1083-90. PubMed ID: 17943957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH; Shields CL; Munier FL; Chantada GL
    JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the management of retinoblastoma.
    Shields CL; Shields JA
    J Pediatr Ophthalmol Strabismus; 1999; 36(1):8-18; quiz 35-6. PubMed ID: 9972509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History of retinoblastoma].
    Rehůrek J
    Cesk Slov Oftalmol; 1997 Dec; 53(6):351-5. PubMed ID: 9476385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.